ASGCT

@ASGCTherapy

Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.

Vrijeme pridruživanja: siječanj 2013.

Tweetovi

Blokirali ste korisnika/cu @ASGCTherapy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ASGCTherapy

  1. prije 6 sati

    Did you know there are more than 400 active and recruiting clinical trials in and across the U.S.? You can search them using our Clinical Trials Finder, which is updated daily.

    Poništi
  2. prije 7 sati

    “I can breathe again. This is the beginning of my new life,” says Lynnette Williams-Briggs, 60, the first patient in Delaware to receive .

    Poništi
  3. prije 13 sati

    Next month, is hosting a workshop focused on financing strategies to make and accessible and sustainable. Learn more and register here:

    Poništi
  4. prije 14 sati

    The preliminary schedule for is available now on the free meeting app! Download the app on your phone or computer and you'll be able to search speakers, sessions, and more as they're updated in real time.

    Poništi
  5. 5. velj

    In hopes it will create a model for the future, the Initiative announced this week it will give grants and other resources to 30 patient groups working to treat .

    Poništi
  6. 4. velj

    Since today is , we want to share some resources that may help patients currently in the fight. is a treatment approach that modifies immune system cells to recognize and kill cells. Learn more here:

    Poništi
  7. 4. velj

    First , now ? editing could allow clinicians to make temporary fixes that eliminate mutations in proteins, halt their production, or change the way that they work in specific organs and tissues.

    Poništi
  8. 4. velj

    In order to be the most trusted source of information on the science and application of and , we'll provide timely and accurate updates to patient communities, the public, and the media. Read more in our strategic plan:

    Poništi
  9. 4. velj

    A mechanism recently discovered by researchers regulates activity in cells by targeting , which plays an important role in cellular activity.

    Poništi
  10. 4. velj

    Have you watched our webinars with ? This series of patient education webinars covers the process and science behind , the 's role in it, what happens to patients after they're treated, and more. Watch them all here:

    Poništi
  11. 3. velj

    . researchers have identified the mechanism that prevents destruction of cells by .

    Poništi
  12. 3. velj

    Today on the blog, read our statement on the 's newly-released guidance documents by Dr. Adora Ndu.

    Poništi
  13. 3. velj

    " has offered a path, not fulfilled by any other means of translational medicine," writes ' Jerry Mendell, M.D., an ASGCT Member, in .

    Poništi
  14. 3. velj

    Piper became the first newborn in Wisconsin to test positive for since the state began testing in October. In December, she became the state's first child identified through screening to get for the disease, reports.

    Poništi
  15. 31. sij

    Combining infusions of cancer-killing T cells with an experimental could boost effectiveness of in , according to researchers.

    Poništi
  16. 31. sij

    It's our job to advocate for maximized access to and so that more of the patients who need these treatments can get them. Read the "Access" section of our strategic plan to learn how we'll work toward this goal.

    Poništi
  17. 31. sij

    Our abstract submission window for is now closed! Thanks to everyone who submitted their research. Presentation status notifications will be sent on April 6. We hope to see you in Boston in May!

    Poništi
  18. 31. sij

    In a lab at , researchers have developed an update to called TREE—Transient Reporter for Editing Enrichment—which allows for more accurate single-DNA base editing, reports.

    Poništi
  19. 31. sij

    TODAY is your last day to submit abstracts for ! Submit by 1:59 p.m. for your chance to present your research at the 23rd Annual Meeting. If you're having last-minute issues, here's how to get help:

    Poništi
  20. 30. sij

    . scientists have found that T-cell stimulation could be used to target cancers with a common gene mutation.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·